Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about EXERCISE: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
EXERCISE is a concept in neurodegeneration research. Key relationships include: activates, therapeutic target, regulates. Associated with Aging, Als, Alzheimer. Connected to 672 entities in the SciDEX knowledge graph.
| Name | EXERCISE |
| Summary | Phase 1 clinical trial evaluating adaptive deep brain stimulation during exercise in Parkinson's disease patients at University of Colorado Denver |
| Key Genes/Proteins | TNF-Α, BDNF, ALZHEIMER |
| Related Diseases | Als, Depression, Aging, Alzheimer, Parkinson |
| Related Pathways | Oxidative Stress |
| Linked Hypotheses | 2 hypotheses |
Knowledge base pages for this entity
graph TD
EXERCISE["EXERCISE"]
EXERCISE -->|"inhibits"| BMAL1["BMAL1"]
EXERCISE -->|"inhibits"| TNF__["TNF-Alpha"]
EXERCISE -->|"activates"| BDNF["BDNF"]
EXERCISE -->|"activates"| PPARGC1A["PPARGC1A"]
EXERCISE -->|"activates"| LEARNING["LEARNING"]
EXERCISE -->|"activates"| MEMORY["MEMORY"]
EXERCISE -.protects against.-> depression["depression"]
EXERCISE -->|"activates"| serotonin["serotonin"]
CAV1["CAV1"] -->|"regulates"| EXERCISE
AMPK["AMPK"] -->|"regulates"| EXERCISE
SIRT1["SIRT1"] -->|"activates"| EXERCISE
FOXO1["FOXO1"] -->|"activates"| EXERCISE
P38["P38"] -->|"activates"| EXERCISE
CREB1["CREB1"] -->|"activates"| EXERCISE
PPARGC1A -->|"activates"| EXERCISE
PTEN["PTEN"] -->|"target for"| EXERCISE
AKT["AKT"] -->|"target for"| EXERCISE| Target | Relation | Type | Str |
|---|---|---|---|
| TNF-Α | inhibits | gene | 1.00 |
| BDNF | activates | gene | 1.00 |
| Als | activates | disease | 1.00 |
| Als | associated_with | disease | 1.00 |
| Als | therapeutic_target | disease | 1.00 |
| Depression | therapeutic_target | disease | 1.00 |
| Aging | activates | disease | 1.00 |
| Alzheimer | activates | disease | 1.00 |
| Parkinson | activates | disease | 1.00 |
| Oxidative Stress | activates | pathway | 1.00 |
| Neuroinflammation | activates | disease | 1.00 |
| Inflammation | activates | disease | 1.00 |
| ALZHEIMER | activates | gene | 1.00 |
| Insulin Resistance | activates | disease | 1.00 |
| Neurodegeneration | activates | disease | 1.00 |
| Inflammation | inhibits | disease | 1.00 |
| AMPK | activates | gene | 1.00 |
| Apoptosis | activates | pathway | 1.00 |
| CYTOKINES | activates | gene | 1.00 |
| DEPRESSION | therapeutic_target | gene | 1.00 |
| PARKINSON | activates | gene | 1.00 |
| Synaptic Plasticity | activates | pathway | 1.00 |
| BMAL1 | inhibits | gene | 0.95 |
| Als | regulates | disease | 0.95 |
| Diabetes | activates | disease | 0.95 |
| Neurodegeneration | therapeutic_target | disease | 0.95 |
| INFLAMMATION | activates | gene | 0.90 |
| NEUROINFLAMMATION | activates | gene | 0.90 |
| Oxidative Stress | therapeutic_target | pathway | 0.90 |
| BDNF | regulates | gene | 0.90 |
| MITOCHONDRIAL DYSFUNCTION | therapeutic_target | gene | 0.90 |
| IL-6 | activates | gene | 0.90 |
| Inflammation | associated_with | disease | 0.85 |
| Als | inhibits | disease | 0.85 |
| Stroke | activates | disease | 0.85 |
| Parkinson | therapeutic_target | disease | 0.85 |
| Tumor | activates | disease | 0.85 |
| Diabetes | inhibits | disease | 0.85 |
| Sarcopenia | therapeutic_target | disease | 0.85 |
| Diabetes | regulates | disease | 0.85 |
| Inflammation | regulates | disease | 0.85 |
| SIRT1 | activates | gene | 0.80 |
| NEURODEGENERATIVE DISEASES | activates | gene | 0.80 |
| BDNF | therapeutic_target | gene | 0.80 |
| ALZHEIMER'S DISEASE | activates | gene | 0.80 |
| AKT | activates | gene | 0.80 |
| Nf-Κb | therapeutic_target | pathway | 0.80 |
| Autophagy | activates | pathway | 0.80 |
| Nf-Κb | activates | pathway | 0.80 |
| MTOR | activates | gene | 0.80 |
| Source | Relation | Type | Str |
|---|---|---|---|
| OXIDATIVE STRESS | activates | gene | 1.00 |
| AGING | activates | gene | 1.00 |
| INSULIN RESISTANCE | activates | gene | 1.00 |
| NEURODEGENERATION | activates | gene | 1.00 |
| SIRT1 | activates | gene | 0.90 |
| APOPTOSIS | activates | gene | 0.90 |
| NEURODEGENERATION | therapeutic_target | gene | 0.90 |
| OXIDATIVE STRESS | therapeutic_target | gene | 0.90 |
| TNF | activates | gene | 0.90 |
| PARKINSON'S DISEASE | activates | gene | 0.90 |
| INFLAMMATION | activates | gene | 0.90 |
| NEURODEGENERATIVE DISEASES | activates | gene | 0.80 |
| DNA | activates | gene | 0.80 |
| MITOCHONDRIAL DYSFUNCTION | therapeutic_target | gene | 0.80 |
| BDNF | activates | gene | 0.80 |
| FNDC5 | activates | gene | 0.80 |
| NRF2 | activates | gene | 0.80 |
| FOXO1 | activates | gene | 0.70 |
| AGING | associated_with | gene | 0.70 |
| NEURODEGENERATION | associated_with | gene | 0.70 |
| PARKINSON'S DISEASE | associated_with | gene | 0.70 |
| AGING | biomarker_for | gene | 0.70 |
| ALZHEIMER'S DISEASE | activates | gene | 0.70 |
| TNF-Α | activates | gene | 0.70 |
| TAU | therapeutic_target | gene | 0.70 |
| MITOPHAGY | therapeutic_target | gene | 0.70 |
| GENES | activates | gene | 0.70 |
| TRKB | activates | gene | 0.70 |
| PARKINSON | activates | gene | 0.70 |
| NF-ΚB | activates | gene | 0.70 |
| MITOCHONDRIAL DYSFUNCTION | activates | gene | 0.70 |
| HUNTINGTON | activates | gene | 0.70 |
| TFAM | activates | gene | 0.70 |
| PINK1 | activates | gene | 0.70 |
| MITOPHAGY | activates | gene | 0.70 |
| INFLAMMATION | implicated_in | gene | 0.70 |
| PARKINSON'S DISEASE | therapeutic_target | gene | 0.70 |
| AUTOPHAGY | regulates | gene | 0.70 |
| NEURODEGENERATION | inhibits | gene | 0.70 |
| ANXIETY | therapeutic_target | gene | 0.70 |
| INFLAMMATION | inhibits | gene | 0.70 |
| CAV1 | regulates | gene | 0.60 |
| AMPK | regulates | gene | 0.60 |
| AMPK | associated_with | gene | 0.60 |
| REST | associated_with | gene | 0.60 |
| P38 | activates | gene | 0.60 |
| CREB1 | activates | gene | 0.60 |
| PPARGC1A | activates | gene | 0.60 |
| AMPK | activates | gene | 0.60 |
| PTEN | therapeutic_target | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| M1 Muscarinic Receptor Agonism as Pharmacological Exercise S | 0.589 | neurodegeneration | What are the specific circulating factor |
| Complement C1q Suppression as Mechanism Linking Exercise Pla | 0.560 | neurodegeneration | What are the specific circulating factor |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-14 | 2 hypotheses Top: 0.589
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||